Literature DB >> 19444627

Ionizing radiation: a risk factor for mesothelioma.

Julie E Goodman1, Marc A Nascarella, Peter A Valberg.   

Abstract

In the majority of mesothelioma cases worldwide, asbestos is a likely causal factor, but several alternative factors, such as ionizing radiation, have been recognized. We reviewed ionizing-radiation evidence from epidemiology studies of (1) patients exposed to the diagnostic X-ray contrast medium "Thorotrast," (2) patients undergoing radiation therapy (i.e., to treat cancer), and (3) atomic energy workers chronically exposed to lower levels of radiation. The results from these populations are also supported by case reports of mesothelioma following therapeutic radiation. Statistically significant associations were found in many, but not all, epidemiology studies (particularly those of Thorotrast- and radiation-treated patients). Given the low mesothelioma rate in the general population, the consistently increased risk among these radiation-exposed individuals is noteworthy. Many studies were limited by the lack of a uniform manner in which mesothelioma was reported prior to introduction of a uniform classification system (ICD-10). Future studies that rely on ICD-10 should have greater power to detect an association. While the evidence falls short of a definitive causal link, considering studies in which statistical significance was achieved, the case reports, and the plausible mode of action, we conclude that the evidence is supportive of a causal link between ionizing radiation exposure and mesothelioma risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444627     DOI: 10.1007/s10552-009-9357-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  22 in total

1.  Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma.

Authors:  Didier Jean; Emilie Thomas; Elodie Manié; Annie Renier; Aurélien de Reynies; Céline Lecomte; Pascal Andujar; Jocelyne Fleury-Feith; Françoise Galateau-Sallé; Marco Giovannini; Jessica Zucman-Rossi; Marc-Henri Stern; Marie-Claude Jaurand
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 2.  Novel systemic therapy against malignant pleural mesothelioma.

Authors:  Michael R Mancuso; Joel W Neal
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 3.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

4.  Computerized segmentation and measurement of malignant pleural mesothelioma.

Authors:  William F Sensakovic; Samuel G Armato; Christopher Straus; Rachael Y Roberts; Philip Caligiuri; Adam Starkey; Hedy L Kindler
Journal:  Med Phys       Date:  2011-01       Impact factor: 4.071

5.  Analyses of radiation and mesothelioma in the US Transuranium and Uranium Registries.

Authors:  Herman Gibb; Keri Fulcher; Sumitha Nagarajan; Stacey McCord; Naz Afarin Fallahian; Heather J Hoffman; Cary Haver; Sergei Tolmachev
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

Review 6.  Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas.

Authors:  Lynnette Fernandez-Cuesta; Lise Mangiante; Nicolas Alcala; Matthieu Foll
Journal:  Virchows Arch       Date:  2021-01-07       Impact factor: 4.064

Review 7.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Authors:  Michele Carbone; Prasad S Adusumilli; H Richard Alexander; Paul Baas; Fabrizio Bardelli; Angela Bononi; Raphael Bueno; Emanuela Felley-Bosco; Francoise Galateau-Salle; David Jablons; Aaron S Mansfield; Michael Minaai; Marc de Perrot; Patricia Pesavento; Valerie Rusch; David T Severson; Emanuela Taioli; Anne Tsao; Gavitt Woodard; Haining Yang; Marjorie G Zauderer; Harvey I Pass
Journal:  CA Cancer J Clin       Date:  2019-07-08       Impact factor: 508.702

Review 8.  Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review.

Authors:  Andrew C Miller; Markku Miettinen; David S Schrump; Raffit Hassan
Journal:  Ann Am Thorac Soc       Date:  2014-09

9.  Factors that impact susceptibility to fiber-induced health effects.

Authors:  Jennifer E Below; Nancy J Cox; Naomi K Fukagawa; Ari Hirvonen; Joseph R Testa
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

10.  NLRP1 polymorphisms in patients with asbestos-associated mesothelioma.

Authors:  Martina Girardelli; Iva Maestri; Rosa R Rinaldi; Mauro Tognon; Renzo Boldorini; Massimo Bovenzi; Sergio Crovella; Manola Comar
Journal:  Infect Agent Cancer       Date:  2012-10-02       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.